391 related articles for article (PubMed ID: 36412458)
1. Application and development of fecal microbiota transplantation in the treatment of gastrointestinal and metabolic diseases: A review.
Mahmoudi H; Hossainpour H
Saudi J Gastroenterol; 2023; 29(1):3-11. PubMed ID: 36412458
[TBL] [Abstract][Full Text] [Related]
2. Fecal microbiota transplantation: past, present and future.
Aroniadis OC; Brandt LJ
Curr Opin Gastroenterol; 2013 Jan; 29(1):79-84. PubMed ID: 23041678
[TBL] [Abstract][Full Text] [Related]
3. Are There Potential Applications of Fecal Microbiota Transplantation beyond Intestinal Disorders?
Zhou Y; Xu H; Huang H; Li Y; Chen H; He J; Du Y; Chen Y; Zhou Y; Nie Y
Biomed Res Int; 2019; 2019():3469754. PubMed ID: 31467881
[TBL] [Abstract][Full Text] [Related]
4. Changes in microbial ecology after fecal microbiota transplantation for recurrent C. difficile infection affected by underlying inflammatory bowel disease.
Khanna S; Vazquez-Baeza Y; González A; Weiss S; Schmidt B; Muñiz-Pedrogo DA; Rainey JF; Kammer P; Nelson H; Sadowsky M; Khoruts A; Farrugia SL; Knight R; Pardi DS; Kashyap PC
Microbiome; 2017 May; 5(1):55. PubMed ID: 28506317
[TBL] [Abstract][Full Text] [Related]
5. Fecal microbiota transplantation beyond Clostridioides difficile infections.
Wortelboer K; Nieuwdorp M; Herrema H
EBioMedicine; 2019 Jun; 44():716-729. PubMed ID: 31201141
[TBL] [Abstract][Full Text] [Related]
6. Is fecal microbiota transplantation (FMT) an effective treatment for patients with functional gastrointestinal disorders (FGID)?
Pinn DM; Aroniadis OC; Brandt LJ
Neurogastroenterol Motil; 2015 Jan; 27(1):19-29. PubMed ID: 25424663
[TBL] [Abstract][Full Text] [Related]
7. Fecal microbiota transplantation for recurrent C. difficile infection in patients with inflammatory bowel disease: experience of a large-volume European FMT center.
Ianiro G; Bibbò S; Porcari S; Settanni CR; Giambò F; Curta AR; Quaranta G; Scaldaferri F; Masucci L; Sanguinetti M; Gasbarrini A; Cammarota G
Gut Microbes; 2021; 13(1):1994834. PubMed ID: 34709989
[TBL] [Abstract][Full Text] [Related]
8. Fecal microbiota transplantation as a new therapy: from Clostridioides difficile infection to inflammatory bowel disease, irritable bowel syndrome, and colon cancer.
Borody TJ; Eslick GD; Clancy RL
Curr Opin Pharmacol; 2019 Dec; 49():43-51. PubMed ID: 31173991
[TBL] [Abstract][Full Text] [Related]
9. Alteration of gut microbial composition associated with the therapeutic efficacy of fecal microbiota transplantation in Clostridium difficile infection.
Lee PC; Chang TE; Wang YP; Lee KC; Lin YT; Chiou JJ; Huang CW; Yang UC; Li FY; Huang HC; Wu CY; Huang YH; Hou MC
J Formos Med Assoc; 2022 Sep; 121(9):1636-1646. PubMed ID: 34836663
[TBL] [Abstract][Full Text] [Related]
10. Fecal microbiota transplantation for recurrent C. difficile infection in patients with inflammatory bowel disease: A systematic review and meta-analysis.
Porcari S; Baunwall SMD; Occhionero AS; Ingrosso MR; Ford AC; Hvas CL; Gasbarrini A; Cammarota G; Ianiro G
J Autoimmun; 2023 Dec; 141():103036. PubMed ID: 37098448
[TBL] [Abstract][Full Text] [Related]
11. FMT: What's Next? A Narrative Review of Fecal Microbiota Transplantation in Clostridioides difficile Infection and Inflammatory Bowel Disease.
Patwa SA; Ward C; Kelly CR
R I Med J (2013); 2022 Nov; 105(9):20-24. PubMed ID: 36300959
[TBL] [Abstract][Full Text] [Related]
12. The Evolving Landscape of Fecal Microbial Transplantation.
Shao T; Hsu R; Hacein-Bey C; Zhang W; Gao L; Kurth MJ; Zhao H; Shuai Z; Leung PSC
Clin Rev Allergy Immunol; 2023 Oct; 65(2):101-120. PubMed ID: 36757537
[TBL] [Abstract][Full Text] [Related]
13. Fecal microbiota transplantation for recurrent Clostridioides difficile infection in patients with concurrent ulcerative colitis.
Porcari S; Severino A; Rondinella D; Bibbò S; Quaranta G; Masucci L; Maida M; Scaldaferri F; Sanguinetti M; Gasbarrini A; Cammarota G; Ianiro G
J Autoimmun; 2023 Dec; 141():103033. PubMed ID: 37085337
[TBL] [Abstract][Full Text] [Related]
14. Clinical Application and Potential of Fecal Microbiota Transplantation.
Ooijevaar RE; Terveer EM; Verspaget HW; Kuijper EJ; Keller JJ
Annu Rev Med; 2019 Jan; 70():335-351. PubMed ID: 30403550
[TBL] [Abstract][Full Text] [Related]
15. Fecal microbiota transplantation: past, present and future perspectives.
Bibbò S; Ianiro G; Gasbarrini A; Cammarota G
Minerva Gastroenterol Dietol; 2017 Dec; 63(4):420-430. PubMed ID: 28927251
[TBL] [Abstract][Full Text] [Related]
16. Fecal microbiota transplantation for irritable bowel syndrome: Current evidence and perspectives.
Dai C; Huang YH; Jiang M
World J Gastroenterol; 2024 Apr; 30(16):2179-2183. PubMed ID: 38690018
[TBL] [Abstract][Full Text] [Related]
17. Fecal microbiota transplantation - methods of treatment of recurrent Clostridium difficile infections and other diseases.
Juszczuk K; Grudlewska K; Mikucka A; Gospodarek E
Postepy Hig Med Dosw (Online); 2017 Mar; 71(0):220-226. PubMed ID: 28345530
[TBL] [Abstract][Full Text] [Related]
18. An overview of fecal microbiota transplantation: techniques, indications, and outcomes.
Brandt LJ; Aroniadis OC
Gastrointest Endosc; 2013 Aug; 78(2):240-9. PubMed ID: 23642791
[No Abstract] [Full Text] [Related]
19. Fecal microbiota transplantation: History, procedure and regulatory considerations.
D T; Venkatesh MP
Presse Med; 2023 Dec; 52(4):104204. PubMed ID: 37944641
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and Outcomes of Faecal Microbiota Transplantation for Recurrent Clostridioides difficile Infection in Children with Inflammatory Bowel Disease.
Nicholson MR; Alexander E; Ballal S; Davidovics Z; Docktor M; Dole M; Gisser JM; Goyal A; Hourigan SK; Jensen MK; Kaplan JL; Kellermayer R; Kelsen JR; Kennedy MA; Khanna S; Knackstedt ED; Lentine J; Lewis JD; Michail S; Mitchell PD; Oliva-Hemker M; Patton T; Queliza K; Sidhu S; Solomon AB; Suskind DL; Weatherly M; Werlin S; de Zoeten EF; Kahn SA;
J Crohns Colitis; 2022 Jun; 16(5):768-777. PubMed ID: 34788420
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]